Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis
The CXC chemokine receptor 2 (CXCR2) on neutrophils, which recognizes chemokines produced at the site of infection, plays an important role in antimicrobial host defenses such as neutrophil activation and chemotaxis. Staphylococcus aureus is a successful human pathogen secreting a number of proteoly...
Saved in:
Published in | The EMBO journal Vol. 31; no. 17; pp. 3607 - 3619 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
29.08.2012
Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The CXC chemokine receptor 2 (CXCR2) on neutrophils, which recognizes chemokines produced at the site of infection, plays an important role in antimicrobial host defenses such as neutrophil activation and chemotaxis.
Staphylococcus aureus
is a successful human pathogen secreting a number of proteolytic enzymes, but their influence on the host immune system is not well understood. Here, we identify the cysteine protease Staphopain A as a chemokine receptor blocker. Neutrophils treated with Staphopain A are unresponsive to activation by all unique CXCR2 chemokines due to cleavage of the N‐terminal domain, which can be neutralized by specific protease inhibitors. Moreover, Staphopain A inhibits neutrophil migration towards CXCR2 chemokines. By comparing a methicillin‐resistant
S. aureus
(MRSA) strain with an isogenic Staphopain A mutant, we demonstrate that Staphopain A is the only secreted protease with activity towards CXCR2. Although the inability to cleave murine CXCR2 limits
in‐vivo
studies, our data indicate that Staphopain A is an important immunomodulatory protein that blocks neutrophil recruitment by specific cleavage of the N‐terminal domain of human CXCR2.
Neutrophil activation and recruitment to the site of infection are critical for host immunity. In humans, the cysteine protease Staphopain A of the pathogen
S. aureus
blocks this process by cleaving the chemokine receptor CXCR2. |
---|---|
Bibliography: | ark:/67375/WNG-BNCXDXG1-7 ArticleID:EMBJ2012212 Supplementary Figures 1-5Review Process File istex:9CDA8B9BEEA135B3C8FE1250D32268B592995D19 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0261-4189 1460-2075 1460-2075 |
DOI: | 10.1038/emboj.2012.212 |